# ELEPSIA XR 1500 MG

NDC: 80705-101
Generic name: levetiracetam
Labeler / Manufacturer: TRIPOINT THERAPEUTICS, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20210212

FDA application: NDA204417

## Active ingredients

- LEVETIRACETAM: 1500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80705-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80705-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cac83d47-88a2-4447-a0c0-90b44ffda0ac